Subclinical Pre-Treatment Sensory Deficits Appear to Predict the Development of Pain and Numbnessin Patients with Multiple Myeloma Undergoing Chemotherapy

PURPOSE: Chemotherapy-induced peripheral neuropathy is a major complication in the treatment of cancer, including multiple myeloma (MM). Patients may develop painful and nonpainful (e.g., numbness) neuropathy symptoms that impair function and often persist after therapy is terminated. This study tes...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Vichaya, Elisabeth G., Wang, Xin Shelley, Boyette-Davis, Jessica A., Mendoza, Tito R., He, Zijing, Thomas, Sheeba K., Shah, Nina, Williams, Loretta A., Cleeland, Charles S., Dougherty, Patrick M.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669643/
https://ncbi.nlm.nih.gov/pubmed/23543296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2152-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares